Domestic and International Exchange Dynamics-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

International Life Extension Research Alliance

Domestic and International Exchange Dynamics

Video Center

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2017-03-16

→

Human tissue and organ cryopreservation technology

At normal temperature, isolated ischemic tissues and organs will die within a short period of time (from a few minutes to a few hours at most) and cannot be used for transplantation. It is impossible to complete the transplant operation in such a short period of time. Therefore, tissue and organ cryopreservation technology is needed to maintain their activity.

2017-03-13

→

Cryoprotectant

Cryoprotectants are the basis for research on cryopreservation of various human cells, tissues, and organs. Since the discovery of the cryoprotective effect of glycerol in the 1960s, more than 50 drugs or reagents have been used for cryoprotection. In recent years, with the development of vitrification technology, in-depth research on cryoprotectants has attracted the attention of many researchers.

2017-03-13

→

Cryogenic equipment

The relationship between the energy difference input to the sample under test and the reference substance and temperature (or time) can be measured through programmable temperature control. The application range is very wide, especially in the research and development, performance testing and quality control of materials, such as glass transition temperature, cold crystallization, phase transition, melting, crystallization, product stability, solidification/cross-linking, oxidation induction period and other research fields.

2016-08-29

→

Ben Best, former president of the American Institute of Human Cryology (CI), visited and exchanged ideas

On the afternoon of August 29, 2016, Ben Best, former president of the American Institute of Human Crystalsis (CI), and Jeremy Yan, president of the Asian Human Crystalsis Company, arrived at the Yinfeng Life Science Foundation in Shandong Province. The two sides had in-depth exchanges on the life extension research program funded by the foundation.

2015-07-19

→

The preparatory group of the foundation inspected the American Institute of Human Cryology CI and Alcor Life Extension Charity Foundation

In July 2015, the preparatory team of the foundation went to the United States to investigate the Institute of Human Cryology (CI). Conduct in-depth exchanges and sign a memorandum of cooperation on human low-temperature preservation research.

2015-06-29

→

Mr. Jose, an expert from Alcor Life Extension Foundation in the United States, visited our hospital for investigation

In June 2015, Mr. Jose from Alcor Life Extension Foundation in the United States visited Yinfeng Biotechnology for investigation. Professor Shen Bojun, Chief Scientist of Yinfeng Biology, Professor Qu Tingyu, Aaron Drake, and others accompanied the reception and exchange.